SCHEMBL13044544

SCHEMBL13044544

CCOC(=O)C(O)c1cccnc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
P2RX7 Q99572 1/20 0.41
BRD4 O60885 1/20 0.41
CASP1 P29466 1/20 0.41
LMNA P02545 2/20 0.40
CYP1A2 P05177 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CYP2C9 P11712 1/20 0.40
HIF1A Q16665 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
FFAR1 O14842 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6181763 0.85 MEN1 (0.46) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL20865742 0.84 CASP1 (0.46) KMT2AMEN1GAASMN1; SMN2BRD4
SCHEMBL27876362 0.84 SMN1; SMN2 (0.44) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL462122 0.84 CASP1 (0.63) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL13984717 0.81 SMN1; SMN2 (0.43) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL1578636 0.81 MEN1 (0.43) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL30288171 0.80 LMNA (0.43) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL29026089 0.80 LMNA (0.43) KMT2AMEN1GAASMN1; SMN2P2RX7
SCHEMBL21767717 0.80 CHRM4 (0.46) KMT2AMEN1GAASMN1; SMN2BRD4
SCHEMBL3639223 0.80 P2RX7 (0.42) P2RX7LMNAMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2010-11-11 US disclosed
WO-2008148853-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GLAXO GROUP LIMITED (GB) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286152-A1 N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR GIPR, GHSR, GLP1R KMT2A 3646/4885MEN1 3070/4885GAA 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.